Benitec Biopharma Statistics Share Statistics Benitec Biopharma has 26.25M
shares outstanding. The number of shares has increased by 160.26%
in one year.
Shares Outstanding 26.25M Shares Change (YoY) 160.26% Shares Change (QoQ) 2.97% Owned by Institutions (%) 56.72% Shares Floating 24.55M Failed to Deliver (FTD) Shares 355 FTD / Avg. Volume 0.36%
Short Selling Information The latest short interest is 1.33M, so 5.18% of the outstanding
shares have been sold short.
Short Interest 1.33M Short % of Shares Out 5.18% Short % of Float 9.69% Short Ratio (days to cover) 33.71
Valuation Ratios The PE ratio is -11.17 and the forward
PE ratio is -4.88.
Benitec Biopharma's PEG ratio is
0.18.
PE Ratio -11.17 Forward PE -4.88 PS Ratio 0 Forward PS 9.5 PB Ratio 4.35 P/FCF Ratio -17.95 PEG Ratio 0.18
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Benitec Biopharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 54.67,
with a Debt / Equity ratio of 0.01.
Current Ratio 54.67 Quick Ratio 54.67 Debt / Equity 0.01 Debt / EBITDA -0.02 Debt / FCF -0.04 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.37M Employee Count 16 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 60.11% in the
last 52 weeks. The beta is 0.43, so Benitec Biopharma's
price volatility has been higher than the market average.
Beta 0.43 52-Week Price Change 60.11% 50-Day Moving Average 12.62 200-Day Moving Average 12.85 Relative Strength Index (RSI) 58.39 Average Volume (20 Days) 97,701
Income Statement
Revenue n/a Gross Profit -396K Operating Income -41.77M Net Income -37.92M EBITDA -41.77M EBIT -41.77M Earnings Per Share (EPS) -1.05
Full Income Statement Balance Sheet The company has 97.74M in cash and 849K in
debt, giving a net cash position of 96.89M.
Cash & Cash Equivalents 97.74M Total Debt 849K Net Cash 96.89M Retained Earnings -228.18M Total Assets 105.21M Working Capital 96.98M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -23.59M
and capital expenditures -18K, giving a free cash flow of -23.61M.
Operating Cash Flow -23.59M Capital Expenditures -18K Free Cash Flow -23.61M FCF Per Share -0.65
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields BNTC does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for BNTC is $24,
which is 70.3% higher than the current price. The consensus rating is "Buy".
Price Target $24 Price Target Difference 70.3% Analyst Consensus Buy Analyst Count 5
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 26, 2023. It was a
backward
split with a ratio of 1:17.
Last Split Date Jul 26, 2023 Split Type backward Split Ratio 1:17
Scores Altman Z-Score 25.86 Piotroski F-Score 2
